๐Ÿ„ Peter Brandt talks about โ€œmagic mushrooms.โ€ What if real mushrooms are already becoming technology?

In crypto, ๐Ÿ„ is a metaphor for self-deception: when an investor sees only $1 million per BTC and stops noticing the risks.

But in the real world, mushrooms are already biotechnology, new materials, and AI.

Mushrooms Inc. (OTC: MSRM) announced a Proof of Concept for MycoLabX: mycelium films demonstrated a color change when interacting with bacteria. Potential applications include technologies for the early detection of infections, particularly in wound care.

At the same time, the company is developing MycoLab.ai โ€” an AI platform for working with scientific data on mycology.

But DVA reminds you:

Proof of Concept โ‰  finished product.
Technology โ‰  commercial success.
OTC stock โ‰  guaranteed profit.

MSRM is a very small, high-risk company. So weโ€™re watching the facts, not the attractive story: independent validation, partners, funding, and actual commercialization.

๐Ÿ„ Mushrooms can be technology.
But investors shouldnโ€™t turn into mushrooms themselves.

DVA โ€” facts without hype.

Not financial advice.
Preserving value and time.

#DVA #Biotech #AI #Mycelium #MSRM